Skip to main content
ClinicoEconomics and Outcomes Research: CEOR logoLink to ClinicoEconomics and Outcomes Research: CEOR
. 2021 Mar 15;13:163. doi: 10.2147/CEOR.S309720

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis [Corrigendum]

PMCID: PMC7979321  PMID: 33758519

Zah V, Pelivanovic J, Tatovic S, et al. Clinicoecon Outcomes Res. 2020;12:635–643.

The authors have advised that the Disclosure statement on page 642 is incorrect. The first sentence “Vladimir Zah, Djurdja Vukicevic, and Martina Imro are employees of ZRx Outcomes Research Inc. (institution founded by Endo Pharmaceuticals to conduct the present analysis), and have received grants from Endo Pharmaceuticals Inc” should read “Vladimir Zah, Djurdja Vukicevic, and Martina Imro are employees of ZRx Outcomes Research Inc. (institution funded by Endo Pharmaceuticals to conduct the present analysis), and have received grants from Endo Pharmaceuticals Inc”.

The authors apologize for this error.


Articles from ClinicoEconomics and Outcomes Research: CEOR are provided here courtesy of Dove Press

RESOURCES